Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05627882 · ClinicalTrials.gov registry record
Evaluation of the Impact of a Forward Viewing Scope at Time of ERCP
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 163
- Enrollment target
NCT05627882 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 163 participants.
The verdict
NCT05627882 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 163 participants
- Enrollment target
Study Summary
This study will be a prospective, tandem-designed study to determine the proportion of clinically significant missed lesions when using a side- or oblique-viewing endoscope as compared to the standard forward-viewing endoscope. Utilizing standard endoscopy protocols in current practice at Brigham and Women's Hospital, consecutive adult patients undergoing ERCP for traditional reasons will undergo back-to-back tandem EGD and ERCP examinations. This process entails an EGD performed by an attending gastroenterologist first. Next, a second blinded attending gastroenterologist will perform ERCP immediately after index EGD. Both endoscopists will note any clinically significant findings, independent of the other providers procedural findings. Clinically significant findings defined as endoscopic findings that alter patient management (i.e., esophageal varices, peptic ulcer disease, hemorrhage, mass, etc.) during EGD and ERCP will be recorded. As previously stated, some institutions already routinely perform EGD with every ERCP.
Interventions
- DIAGNOSTIC_TEST Forward viewing endoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2022-10-14 |
| Est. Completion | 2024-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05627882
The ClinicalTrials.gov registry entry for NCT05627882 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Forward viewing endoscope is the first listed.
NCT05627882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05627882 about?
NCT05627882 is a clinical study titled "Evaluation of the Impact of a Forward Viewing Scope at Time of ERCP". This study will be a prospective, tandem-designed study to determine the proportion of clinically significant missed lesions when using a side- or oblique-viewing endoscope as compared to the standard forward-viewing endoscope. Utilizing standard endoscopy protocols in current practice at Brigham an...
What is the current status of trial NCT05627882?
This trial is currently completed. The enrollment target is 163 participants. The study started on 2022-10-14. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT05627882?
The interventions under investigation include: Forward viewing endoscope (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05627882?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.